- AI and infectious disease diagnosis: The review in The Lancet Infectious Diseases discusses how AI can support pathogen detection, clinical decisions, laboratory workflows, and monitoring. Artificial intelligence and infectious disease diagnostics
- AI and antimicrobial resistance: This open-access review examines AI applications in infectious diseases, antibiotic discovery, and the growing challenge of antimicrobial resistance. Challenges and applications of AI in infectious diseases
- AI in public health: The US Centers for Disease Control and Prevention explains how AI can help public health teams analyse information, identify emerging threats, and improve surveillance. CDC: Using AI to Improve Public Health Efficiency and Response Readiness
- Early detection of outbreaks: The World Health Organization describes its Epidemic Intelligence from Open Sources system, which uses AI-supported capabilities to help identify potential public health threats. WHO: Upgrading its Public Health Intelligence System
- A broad scientific review: This 2025 review examines machine learning applications in infectious disease surveillance, diagnosis, and prognosis, including limitations and research opportunities. Machine Learning and AI for Infectious Disease Surveillance, Diagnosis, and Prognosis
Detecting Invisible Enemies Through Medical Imaging
Many infectious diseases leave clues inside the human body before their causes become obvious. These clues may appear in chest X-rays, CT scans, microscopic images, or other medical examinations.
Artificial intelligence can analyse such images and identify patterns associated with particular diseases. For example, researchers have investigated AI systems that assist clinicians in evaluating chest X-rays for signs of pneumonia or tuberculosis.
The technology works by learning statistical patterns from large collections of labelled medical images. When presented with a new image, the trained system estimates whether patterns associated with a particular condition are present.
.png)
This could be valuable in hospitals with heavy workloads, where specialists must examine large numbers of patients. AI might help prioritize suspicious cases or draw attention to abnormalities that require closer examination.
However, an abnormal image does not necessarily reveal which microorganism caused an infection. Different diseases can produce similar appearances, and some infected patients may have normal or inconclusive imaging results.
Consequently, AI-assisted imaging should complement clinical assessment and appropriate laboratory testing rather than replace them.
The Laboratory of the Future
Laboratories are essential to identifying the organisms responsible for infections. Traditional diagnostic approaches include microscopy, culture, antigen testing, and molecular techniques such as polymerase chain reaction.
Each method has strengths and limitations. Some tests provide results quickly, while others require specialized equipment, trained personnel, or additional time.
AI can help laboratories analyse complex results, automate repetitive tasks, and identify patterns in data. In digital microscopy, computer vision systems can assist with recognizing cells and microorganisms. In molecular diagnostics, computational methods can help interpret genetic sequences and distinguish related pathogens.
One particularly promising area is metagenomic sequencing. Instead of testing exclusively for one suspected organism, this approach can examine genetic material in a sample to search for evidence of multiple possible microorganisms. AI may assist in processing the enormous volumes of sequence data generated by such tests.
Yet these techniques require careful interpretation. Genetic material may come from contamination, harmless microorganisms, or organisms that are present without causing the patient's symptoms. Detecting a sequence is not always equivalent to proving an active infection.
The future laboratory will therefore depend on collaboration between automation, microbiology, clinical expertise, and reliable quality-control procedures.
Finding Infections Before They Become Emergencies
Some infections deteriorate rapidly. Sepsis, a life-threatening response to infection that can cause organ dysfunction, is an important example.
Hospitals collect information such as temperature, heart rate, blood pressure, breathing rate, laboratory results, and medical history. AI systems can analyse combinations of these variables to estimate whether a patient may be at increased risk of deterioration.
A carefully validated warning system might alert medical staff earlier than conventional monitoring alone. This could create an opportunity for clinicians to reassess the patient and determine whether urgent investigation or treatment is necessary.
However, predictions are not diagnoses. A high-risk alert does not prove that sepsis is present, and a low-risk score cannot guarantee safety.
Poorly designed systems may produce excessive false alarms or fail to recognize patients whose symptoms differ from those in their training data. Hospitals must therefore evaluate whether an AI system improves real patient outcomes rather than judging it solely by statistical performance.
From Individual Patients to Global Disease Surveillance
AI's role extends beyond the hospital. Infectious diseases spread through communities, transport networks, workplaces, schools, and international travel.
Public health authorities may examine laboratory reports, hospital admissions, symptom trends, environmental measurements, and other information to identify emerging outbreaks.
AI can help analyse these different sources and detect unusual patterns that deserve investigation. Language-processing systems can also screen large volumes of public information for reports that may indicate a developing health threat.
The World Health Organization's Epidemic Intelligence from Open Sources initiative illustrates how digital information can support public health surveillance. Its updated system, launched in October 2025, incorporates AI capabilities to help public health professionals identify potential threats.
Such tools can improve the speed of information processing, but they must distinguish genuine signals from rumours, duplicate reports, seasonal changes, and unrelated events.
A sudden increase in online discussions about fever, for example, may reflect a real outbreak, heightened public concern, or simply increased media coverage.
Reliable outbreak detection therefore requires epidemiologists to combine computational findings with laboratory confirmation, field investigations, and local knowledge.
The Challenge of Antibiotic Resistance
Another important application of AI concerns antimicrobial resistance.
Antibiotics have transformed medicine, but bacteria can develop resistance to medicines that previously controlled them. Infections caused by resistant bacteria may become more difficult to treat, increasing the risk of complications and prolonged hospitalization.
AI may help researchers identify promising antibiotic candidates, analyse bacterial genetic information, and estimate resistance patterns. In clinical settings, decision-support systems may help clinicians interpret susceptibility results and select appropriate treatment options.
However, AI should not encourage the unnecessary use of antibiotics. Viral infections do not respond to antibacterial medicines, and inappropriate prescribing can contribute to resistance.
The appropriate treatment depends on the suspected organism, the patient's condition, laboratory results, local resistance patterns, allergies, and other clinical considerations.
AI can support this decision-making process, but qualified healthcare professionals must remain responsible for treatment decisions.
A Future That Must Remain Human
Despite its potential, AI introduces serious questions about privacy, fairness, accountability, and reliability.
Medical data can contain highly sensitive information. Health systems must protect patient records, limit unnecessary access, and establish clear rules governing how information is stored and used.
Another concern is unequal performance. An AI model trained primarily on patients from one country or demographic group may perform less accurately in another population. Differences in disease prevalence, laboratory equipment, clinical practice, and access to healthcare can affect its results.
This is particularly important for countries where medical facilities have limited resources. A sophisticated diagnostic system will be of little practical value if hospitals lack reliable electricity, trained personnel, suitable testing equipment, or affordable access to the technology.
Successful implementation requires local validation, staff training, transparent oversight, and continued monitoring.
The most useful future is not one in which machines replace medical professionals. It is one in which technology helps clinicians detect danger earlier, investigate more efficiently, and make better-informed decisions.
Conclusion: Finding Infection Before It Finds Us
AI is opening new possibilities for recognizing infectious diseases, interpreting laboratory results, monitoring vulnerable patients, and identifying emerging outbreaks.
Its greatest potential lies in connecting information that might otherwise remain scattered across medical records, diagnostic laboratories, research databases, and public health systems.
Nevertheless, identifying a possible infection is only the beginning. The finding must be verified, interpreted in context, communicated clearly, and translated into appropriate care.
The promise of AI is not that machines will never make mistakes. It is that, when carefully developed and responsibly used, they may help people recognize important warning signs sooner.
Infectious diseases will continue to challenge humanity. But combining medical expertise, scientific research, laboratory testing, and responsible artificial intelligence could strengthen our ability to respond.
The future of infection detection will depend not on technology alone, but on how wisely humanity chooses to use it.